Publications by authors named "Francesca Calabretta"

Claim this Profile
M
Minimum Inhibitory Concentration Increase in Isolates from Patients with Recurrence: Results from a Retrospective Single-Centre Cohort Study.
Pietro Valsecchi, Erika Asperges, Marta Corbella, Greta Banfi, Marcello Maffezzoni, Francesca Calabretta

Microorganisms· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematological sequelae in the post-acute phase of symptomatic SARS-CoV-2 infection.
Gaetano Bergamaschi, Chiara Barteselli, Francesca Calabretta, Marco Vincenzo Lenti, Stefania Merli

Intern Emerg Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in chronic gastrointestinal disorders.
Federica Melazzini, Francesca Calabretta, Marco Vincenzo Lenti, Antonio Di Sabatino

Expert Rev Gastroenterol Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients.
Paola S Preti, Mariaconcetta Russo, Luca Caneva, Margherita Reduzzi, Francesca Calabretta

Thromb Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia in patients with Covid-19: pathogenesis and clinical significance.
Gaetano Bergamaschi, Federica Borrelli de Andreis, Nicola Aronico, Marco Vincenzo Lenti, Chiara Barteselli, Francesca Calabretta

Clin Exp Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance.
Gaetano Bergamaschi, Federica Borrelli de Andreis, Nicola Aronico, Marco Vincenzo Lenti, Chiara Barteselli, Francesca Calabretta

Clin Exp Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pemetrexed monotherapy in previously treated patients with advanced non small cell lung cancer; differences by histology. Our experience].
Giorgio Pistillucci, Venerina Sciacca, Alida Ciorra, Teresa Di Palma, Francesca Calabretta

Recenti Prog Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?
Andrea Pace, Cecilia Nisticò, Federica Cuppone, Emilio Bria, Edvina Galiè, Francesca Calabretta

Clin Breast Cancer· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients.
Cecilia Nisticò, Emilio Bria, Federica Cuppone, Armando Carpino, Gianluigi Ferretti, Francesca Calabretta

Anticancer Drugs· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab].
Emilio Bria, Barbara Vanni, Federica Cuppone, Francesca Calabretta, Carla Campanella

Suppl Tumori· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis